Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00212446 · ClinicalTrials.gov registry record · NA

Pilot Study to Evaluate a Prototype Electronic Uterine Inhibitor to Prevent Preterm Contractions

A NA study of Preterm Birth, sponsored by St. Luke's-Roosevelt Hospital Center.

Completed
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT00212446: Completed NA study of Preterm Birth, sponsored by St. Luke's-Roosevelt Hospital Center.

NCT00212446 is a NA study of Preterm Birth that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 8 participants, below the 4,409-participant average among 39 other Preterm Birth trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00212446, a NA study of Preterm Birth, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Use an electrical-inhibition (EI)/uterine pacemaker device similar to an electrical heart pacemaker to deliver a weak electrical current to the human uterus that will rapidly and safely inhibit the unwanted premature uterine contractions of preterm birth.

Primary Outcome

The first 20 minutes are the control contraction period (C1). The second 20 minutes are the EI period, with a 10-second burst of current administered just prior to each expected contraction; expected contractions are determined by the timing of the C1 contractions and/or by the rise of the subjective tocodynamometer tracing above baseline levels. The third 20 minutes is the post-intervention control contraction period (C2).

Conditions Studied

Interventions

  • DEVICE Electrical Intervention (EI)

Study Locations (1)

New York

  • St. Luke's-Roosevelt Hospital Center - New York

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2005-02
Est. Completion 2012-04
Phase NA

What the finished NCT00212446 record still lists

NCT00212446 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 4,409-participant average among 39 other Preterm Birth trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which Electrical Intervention (EI) is the first listed.

NCT00212446 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00212446 about?

NCT00212446 is a clinical study titled "Pilot Study to Evaluate a Prototype Electronic Uterine Inhibitor to Prevent Preterm Contractions". Use an electrical-inhibition (EI)/uterine pacemaker device similar to an electrical heart pacemaker to deliver a weak electrical current to the human uterus that will rapidly and safely inhibit the unwanted premature uterine contractions of preterm birth.

What is the current status of trial NCT00212446?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2005-02. Estimated completion is 2012-04.

What conditions does trial NCT00212446 study?

This clinical trial studies the following conditions: Preterm Birth.

What interventions are being tested in trial NCT00212446?

The interventions under investigation include: Electrical Intervention (EI) (DEVICE).

Who is sponsoring clinical trial NCT00212446?

This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00212446 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00212446's enrollment target sits among peer trials

8 39th of 39 higher than 1 of 39 other Preterm Birth trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00212446, the US trial registry maintained by the National Library of Medicine. NCT00212446 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.